This page shows the latest Finch Therapeutics news and features for those working in and with pharma, biotech and healthcare.
In race to be first-to-market in C diff. Finch Therapeutics has completed a Series C financing, raising $53m to advance its microbiome therapies pipeline. ... Earlier this year, Finch gained a breakthrough therapy designation (BTD) from the FDA for
Boost for firm as it races rivals in microbiome space. Finch Therapeutics has won a breakthrough designation (BTD) from the FDA for CP101, a drug for serious Clostridium difficile infections based ... Takeda bought into the programme in 2017, and is also
Takeda has been actively seeking out companies working in this area - forging deals with Enterome (which is also working with Bristol-Myers Squibb), Finch Therapeutics and most recently NuBiyota to build
More from news
Approximately 2 fully matching, plus 1 partially matching documents found.
No results were found
JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...